0 Commentaires
0 Parts
757 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Is Driven By Growing Incidences Of Neuroendocrine TumorsPeptide receptor radionuclide therapy or PRRT is a type of cancer treatment that combines peptides tagged with radioactive elements or radiopharmaceuticals. PRRT involves the use of radiolabeled molecules that target receptors on cancer cells. These receptors overexpress on neuroendocrine tumors which enables the targeting of cancer cells. The radioisotopes delivered by the peptides allows for...0 Commentaires 0 Parts 635 Vue 0 Aperçu
- Italy Peptide Receptor Radionuclide Therapy Market is Estimated to Witness Substantial GrowthSWOT Analysis Strength: The Italy Peptide Receptor Radionuclide Therapy market has strong growth potential due to rising cancer prevalence in the country. Rapid advances in targeted radiopharmaceuticals provides more effective treatment options. Growing awareness about therapeutic nuclear medicine applications amongst patients and healthcare providers fuels market expansion. Weakness: High...0 Commentaires 0 Parts 582 Vue 0 Aperçu
- Peptide Receptor Radionuclide Therapy Gaining Popularity in ItalyPeptide receptor radionuclide therapy, also known as PRRT, is an emerging treatment option for neuroendocrine tumours (NETs) in Italy. This novel form of targeted radiotherapy is showing promising results and is being adopted by more oncology facilities across the country. PRRT is a type of systemic radiotherapy where small amounts of radioactive substances are attached to peptides that bind to...0 Commentaires 0 Parts 716 Vue 0 Aperçu
- Oncology Radiopharmaceuticals Is Estimated To Witness High Growth Owing To Increasing Incidence of CancerSWOT Analysis Strength: The oncology radiopharmaceuticals market experiences strong growth due to the rising preference for precision medicine and targeted radiotherapy among oncologists. Radiopharmaceuticals help diagnose and treat cancer more accurately. The market witnesses numerous product approvals and launches each year to fulfill the increasing demand. Weakness: High costs associated...0 Commentaires 0 Parts 853 Vue 0 Aperçu
- Telehealth Is Fastest Growing Segment Fueling The Growth Of Oncology Radiopharmaceuticals MarketMarket key trends: One of the key trends witnessed in the market currently is the rise in use of theragnostic radiopharmaceuticals. Theragnostics combines therapeutics and diagnostics into a single drug which allows personalizing treatments for patients. These radiopharmaceuticals help improve clinical outcomes by allowing providers to accurately diagnose the disease and simultaneously treat it...0 Commentaires 0 Parts 750 Vue 0 Aperçu